4BIO Capital
Investor profile
4BIO Capital has backed 4 European tech companies across 5 funding rounds between 2020 and 2026, joining rounds totalling €206M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
5
distinct rounds
Companies
4
backed
Active span
2020–2026
7 yrs
Total round €
€206M
sum of rounds joined
Deals by year
distinct rounds / year4BIO Capital — deals by year — interactive chart.
Data table
| 4BIO Capital — deals by year | |
|---|---|
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2026 | 1 |
Top sectors
by deals4BIO Capital — top sectors — interactive chart.
Data table
| 4BIO Capital — top sectors | |
|---|---|
| Healthtech | 5 |
Stages
by deals4BIO Capital — stages — interactive chart.
Data table
| 4BIO Capital — stages | |
|---|---|
| Other | 2 |
| Seed | 1 |
| Series A | 1 |
| Series B | 1 |
Countries
by deals4BIO Capital — countries — interactive chart.
Data table
| 4BIO Capital — countries | |
|---|---|
| France | 2 |
| Italy | 1 |
| Switzerland | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- UPMC Enterprises2
- BGF1
- Bpifrance1
- btov Partners1
- CDP Venture Capital1
- CE Ventures1
- Cystic Fibrosis Foundation1
- Eli lilly and company1
- Extend1
- Institute for Follicular Lymphoma Innovation1
- Jeito Capital1
- Meltwind1
- o2h Ventures1
- Origin Capital1
- Pureos Bioventures1
- RD Fund1
- Redalpine1
- Schroders Capital1
- UCB Ventures1
- VI Partners1
- Wille AG1
- XGEN Venture1
- Ysios Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Sparingvision | France | 2 | €120M |
| Aptadir Therapeutics | Italy | 1 | €40M |
| Araris Biotech | Switzerland | 1 | €24M |
| ViaNautis | UK | 1 | €23M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Sparingvision | Series B | €75M | 2022-09 |
| Sparingvision | Other | €45M | 2020-10 |
| Araris Biotech | Other | €24M | 2022-10 |
| ViaNautis | Series A | €23M | 2023-11 |